SHARE...
Surgery – Biopsies Cause Metastasis – New Study finds
Questioning Chemotherapy – Dr. Ralph Moss
New Findings Support Warburg Theory Of Cancer
Kickbacks for Drugs Are Dangerous
Influence of Big Pharma on social media
Dr. Michelakis May 2012 paper published in Oncogene
Common Chemotherapy Drugs and Side Effects
Chemotherapy Does Not Work – Dr. Ralph Moss
Cancer Research – A Super Fraud?
By Jon Barron, “Chemotherapy: An Interesting Option”
British Journal of Cancer DCA Mini Review
Breast Cancer Awareness Month Misleads Women
1 in 3 patients harmed during hospital stay
PhD
, MD
, MD
, MD
, MD
Received 10 January 1989; received in revised form 16 March 1989; accepted 28 July 1989.
A significant contributor to irreversible cell damage has been identified as excessive brain lactate, which can arise in cerebral ischemia. Previous studies have demonstrated that treatment with 25 mg/kg sodium dichloroacetate (DCA) is effective in reducing brain lactate more quickly than no treatment at all when done with an experimental model that causes cerebral ischemia by bilateral carotid ligation combined with systemic hypotension. Our study’s major goal was to look at the brain tissue lactate dose response to DCA because greater doses of the drug may be more efficient. Other metabolites (such as glucose, glycogen, ATP, and phosphocreatine) that may be indirectly impacted by this reaction were also examined. The experimental and treatment groups of adult male Wistar rats were divided, and actual or fictitious ischemia was generated as explained in our prior article. Rats were put to sleep by in situ brain freezing after 30 minutes of reperfusion. Bilateral analyses of the cerebral cortex, hippocampus, and cerebellum were conducted. The dose of DCA had no impact on glucose or glycogen. After ischemia, lactate levels were higher in the cerebral cortex than in the hippocampus, and DCA was more efficient in bringing them down. This shows that the hippocampus has a lower metabolic rate than the cortex. The cerebellum can operate as an in situ tissue control for that metabolite because it did not show a rise in lactate. Some DCA-treated ischemic rats showed significantly different levels of metabolites in one hemisphere, which appeared to reflect a dose effect of DCA on lactate and a significantly different level of ATP and phosphocreatine at the higher doses. Although 25 mg/kg DCA reduces high levels of brain lactate to nonlethal levels, the potential for a greater effect on lactate, ATP, and phosphocreatine at higher doses was revealed by our study.
Link: https://www.annemergmed.com/article/S0196-0644(89)80054-X/abstract
MEDICAL PUBLICATIONS
The Efficacy of Chemotherapy for Cancer
PDF Clinical Trial Publication U of A 2010
F.D.A. Approves Drug for Bone Marrow Disease
Absence of Mutagenic Effects of Sodium Dichloroacetate
Informational Guide:
DCA guide
© 2022 DCA WATCH
RECENT COMMENTS